PPP1R12A
Protein phosphatase 1 regulatory subunit 12A
Also known as: M130, MBS, MYPT1, MYPT1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O14974
- Gene
- PPP1R12A
- Ensembl
- ENSG00000058272
- Chromosome
- 12
- Canonical length
- 1030 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoli,Plasma membrane,Actin filaments,Cytosol
OverviewNCBI Gene
Myosin phosphatase target subunit 1, which is also called the myosin-binding subunit of myosin phosphatase, is one of the subunits of myosin phosphatase. Myosin phosphatase regulates the interaction of actin and myosin downstream of the guanosine triphosphatase Rho. The small guanosine triphosphatase Rho is implicated in myosin light chain (MLC) phosphorylation, which results in contraction of smooth muscle and interaction of actin and myosin in nonmuscle cells. The guanosine triphosphate (GTP)-bound, active form of RhoA (GTP.RhoA) specifically interacted with the myosin-binding subunit (MBS) of myosin phosphatase, which regulates the extent of phosphorylation of MLC. Rho-associated kinase (Rho-kinase), which is activated by GTP. RhoA, phosphorylated MBS and consequently inactivated myosin phosphatase. Overexpression of RhoA or activated RhoA in NIH 3T3 cells increased phosphorylation of MBS and MLC. Thus, Rho appears to inhibit myosin phosphatase through the action of Rho-kinase. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2009]
Canonical amino-acid sequenceUniProt
1030 residues, UniProt reviewed canonical sequence.
>O14974|PPP1R12A
1 MKMADAKQKR NEQLKRWIGS ETDLEPPVVK RQKTKVKFDD GAVFLAACSS GDTDEVLKLL
61 HRGADINYAN VDGLTALHQA CIDDNVDMVK FLVENGANIN QPDNEGWIPL HAAASCGYLD
121 IAEFLIGQGA HVGAVNSEGD TPLDIAEEEA MEELLQNEVN RQGVDIEAAR KEEERIMLRD
181 ARQWLNSGHI NDVRHAKSGG TALHVAAAKG YTEVLKLLIQ AGYDVNIKDY DGWTPLHAAA
241 HWGKEEACRI LVDNLCDMEM VNKVGQTAFD VADEDILGYL EELQKKQNLL HSEKRDKKSP
301 LIESTANMDN NQSQKTFKNK ETLIIEPEKN ASRIESLEQE KVDEEEEGKK DESSCSSEED
361 EEDDSESEAE TDKTKPLASV TNANTSSTQA APVAVTTPTV SSGQATPTSP IKKFPTTATK
421 ISPKEEERKD ESPATWRLGL RKTGSYGALA EITASKEGQK EKDTAGVTRS ASSPRLSSSL
481 DNKEKEKDSK GTRLAYVAPT IPRRLASTSD IEEKENRDSS SLRTSSSYTR RKWEDDLKKN
541 SSVNEGSTYH KSCSFGRRQD DLISSSVPST TSTPTVTSAA GLQKSLLSST STTTKITTGS
601 SSAGTQSSTS NRLWAEDSTE KEKDSVPTAV TIPVAPTVVN AAASTTTLTT TTAGTVSSTT
661 EVRERRRSYL TPVRDEESES QRKARSRQAR QSRRSTQGVT LTDLQEAEKT IGRSRSTRTR
721 EQENEEKEKE EKEKQDKEKQ EEKKESETSR EDEYKQKYSR TYDETYQRYR PVSTSSSTTP
781 SSSLSTMSSS LYASSQLNRP NSLVGITSAY SRGITKENER EGEKREEEKE GEDKSQPKSI
841 RERRRPREKR RSTGVSFWTQ DSDENEQEQQ SDTEEGSNKK ETQTDSISRY ETSSTSAGDR
901 YDSLLGRSGS YSYLEERKPY SSRLEKDDST DFKKLYEQIL AENEKLKAQL HDTNMELTDL
961 KLQLEKATQR QERFADRSLL EMEKRERRAL ERRISEMEEE LKMLPDLKAD NQRLKDENGA
1021 LIRVISKLSKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PPP1R12A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.55
- Highest tissue expression
- 92 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 92 nTPM
- seminal vesicle: 80 nTPM
- smooth muscle: 78 nTPM
- colon: 69 nTPM
- esophagus: 67 nTPM
- urinary bladder: 66 nTPM
Single-cell type
- neutrophils: 2,038 nCPM
- neutrophil progenitors: 1,425 nCPM
- smooth muscle cells: 1,027 nCPM
- vascular smooth muscle cells: 813 nCPM
- sertoli cells: 523 nCPM
- salivary myoepithelial cells: 511 nCPM
Immune cell
- eosinophil: 198 nTPM
- neutrophil: 188 nTPM
- basophil: 156 nTPM
- NK-cell: 99 nTPM
- non-classical monocyte: 71 nTPM
- T-reg: 70 nTPM
Brain region
- cerebral cortex: 87 nTPM
- basal ganglia: 67 nTPM
- white matter: 67 nTPM
- cerebellum: 65 nTPM
- hippocampal formation: 63 nTPM
- amygdala: 56 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PPP1R12A.
Disease | AllUniProt
Conditions PPP1R12A is implicated in, by any mechanism.
- Genitourinary and/or brain malformation syndrome (GUBS) MIM:618820
Disease | GeneticClinVar
35 pathogenic / likely-pathogenic of 302 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Genitourinary and/or brain malformation syndrome
- PPP1R12A-related disorder
- Inborn genetic diseases
- Differences in sex development
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.13
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.64
- DepMap mean gene effect
- -1.24
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to xenobiotic stimulus
- centrosome cycle
- mitotic cell cycle
- negative regulation of catalytic activity
- neuron projection morphogenesis
- positive regulation of transcription by RNA polymerase II
- protein dephosphorylation
- regulation of cell adhesion
- regulation of nucleocytoplasmic transport
- signal transduction
Molecular functions
- 14-3-3 protein binding
- enzyme inhibitor activity
- myosin phosphatase regulator activity
- phosphatase regulator activity
- protein kinase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PPP1R12A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PPP1R12A as an antibody target. Whether an autoantibody or antibody against PPP1R12A could matter depends on whether native PPP1R12A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PPP1R12A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PPP1R12A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...